TCM Syndrome-based External Treatment of Otitis Media Effusion in Children Using Sun's Sequential Therapy
1.Beijing University of Chinese Medicine,Beijing 100029,China
2.Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,China
3.Wang Jing Hospital of CACMS,Beijing 100102,China
*Corresponding author:SUN Shuchen,Chief physician;E-mail:sunsc0922@163.com
CHEN Qifeng,SUN Shuchen,LIU Rui, et al. TCM Syndrome-based External Treatment of Otitis Media Effusion in Children Using Sun's Sequential Therapy [J]. Chinese General Practice, 2020, 23(33): 4227-4235. DOI: 10.12114/j.issn.1007-9572.2020.00.498.
陈其凤,孙书臣,刘瑞等. 中医鼻病序贯疗法外治法辨证治疗分泌性中耳炎的疗效研究[J]. 中国全科医学, 2020, 23(33): 4227-4235. DOI: 10.12114/j.issn.1007-9572.2020.00.498.
[1]PRINCIPI N,MARCHISIO P,ESPOSITO S.Otitis media with effusion:benefits and harms of strategies in use for treatment and prevention[J].Expert Rev Anti Infect Ther,2016,14:415-423.DOI:10.1586/14787210.2016.1150781.
[2]ZIELHUIS G,RACH G,VAN DEN BROEK P.Screening for otitis media with effusion in preschool children[J].Lancet,1989,333(8633):311-314.DOI:10.1016/s0140-6736(89)91317-2.
[3]HOGAN S C,STRATFORD K J,MOORE D R.Duration and recurrence of otitis media with effusion in children from birth to 3 years:prospective study using monthly otoscopy and tympanometry[J].BMJ,1997,314(7077):350-353.DOI:10.1136/bmj.314.7077.350.
[4]WILLIAMSON I G,DUNLEAVEY J,BAIN J,et al.The natural history of otitis media with effusion——a three-year study of the incidence and prevalence of abnormal tympanograms in four South West Hampshire infant and first schools[J].J Laryngol Otol,1994,108(11):930-934.DOI:10.1017/s0022215100128567.
[5]潘广新,林桂渺,何静春,等.鼻粘膜给药研究进展[J].局解手术学杂志,2005,14(4):270-271.
PAN G X,LIN G M,HE J C,et al.Progression on intranasal administration[J].Journal of Regional Anatomy and Operative Surgery,2005,14(4):270-271.
[6]PARIKH S R,CORONEL M,LEE J J,et al.Validation of a new grading system for endoscopic examination of adenoid hypertrophy[J].Otolaryngol Head Neck Surg,2006,135(5):684-687.DOI:10.1016/j.otohns.2006.05.003.
[7]ZHAO H,MIAO M S.The application characteristics of Zhongjing external prescription medicine[J].Saudi J Biol Sci,2017,24(8):1903-1906.DOI:10.1016/j.sjbs.2017.11.034.
[8]ROSENFELD R M,SHIN J J,SCHWARTZ S R,et al.Clinical practice guideline:otitis media with effusion (update)[J].Otolaryngol Head Neck Surg,2016,154(1 Suppl):S1-41.DOI:10.1177/0194599815623467.
[9]WILLIAMSON I,BENGE S,BARTON S,et al.Topical intranasal corticosteroids in 4-11 year old children with persistent bilateral otitis media with effusion in primary care:double blind randomised placebo controlled trial[J].BMJ,2009,339:b4984.DOI:10.1136/bmj.b4984.
[10]CLOSE R M,ROSENFELD D K.Natural history of untreated otitis media[J].Laryngoscope,2003:113.DOI:10.1097/00005537-200310000-00004.
[11]LIN J,CAYE-THOMASEN P,TONO T,et al.Mucin production and mucous cell metaplasia in otitis media[J].Int J Otolaryngol,2012:745325.DOI:10.1155/2012/745325.
[12]OLSON A L,KLEIN S W,CHARNEY E,et al.Prevention and therapy of serous otitis media by oral decongestant:a double-blind study in pediatric practice[J].Pediatrics,1978,61(5):679-684.
[13]KLEIN S W,OLSON A L,PERRIN J,et al.Prevention and treatment of serous otitis media with an oral antihistamine[J].Clin Pediatr (Phila),1980,19(5):342-347.DOI:10.1177/000992288001900506.
[14]HAUGETO O K,SCHR?DER K E,MAIR I W.Secretory otitis media,oral decongestant and antihistamine[J].J Otolaryngol,1981,10(5):359-362.
[15]DUSDIEKER L B,SMITH G,BOOTH B M,et al.The long-term outcome of nonsuppurative otitis media with effusion[J].Clin Pediatr (Phila),1985,24(4):181-186.DOI:10.1177/000992288502400401.
[16]CANTEKIN E I,MANDEL E M,BLUESTONE C D,et al.Lack of efficacy of a decongestant-antihistamine combination for otitis media with effusion (“secretory” otitis media) in children.Results of a double-blind,randomized trial[J].N Engl J Med,1983,308(6):297-301.DOI:10.1056/NEJM198302103080601.
[17]MANDEL E M,ROCKETTE H E,BLUESTONE C D,et al.Efficacy of amoxicillin with and without decongestant-antihistamine for otitis media with effusion in children.Results of a double-blind,randomized trial[J].N Engl J Med,1987,316(8):432-437.DOI:10.1056/NEJM198702193160803.
[18]VAN ZON A,VAN DER HEIJDEN G J,VAN DONGEN T M,et al.Antibiotics for otitis media with effusion in children[J].Cochrane Database Syst Rev,2012(9):CD009163.DOI:10.1002/14651858.CD009163.pub2.
[19]HALL-STOODLEY L,HU F Z,GIESEKE A,et al.Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media[J].JAMA,2006,296(2):202-211.DOI:10.1001/jama.296.2.202.
[20]CHEN K T,WU X,JIANG G L,et al.Low dose macrolide administration for long term is effective for otitis media with effusion in children[J].Auris Nasus Larynx,2013,40(1):46-50.DOI:10.1016/j.anl.2012.05.008.
[21]抗生素治疗儿童分泌性中耳炎[J].国外医药(抗生素分册),1998,19(4):312-321.
[22]王瑞花.抗生素治疗儿童分泌性中耳炎[J].国外医学?耳鼻咽喉科学分册,1991,15(3):166-167.
[23]BABIC I,BAUDOIN T,TROTIC R,et al.Therapeutic efficacy of azithromycin and acetylcysteine in chronic otitis media with effusion[J].Eur Arch Otorhinolaryngol,2017,274(3):1351-1356.DOI:10.1007/s00405-016-4389-3.
[24]陈阳,张旭,邱建华.头孢克洛和氨溴索治疗分泌性中耳炎的临床观察[J].听力学及言语疾病杂志,2004,12(1):38-39.
[25]BHARGAVA R,CHAKRAVARTI A.A double-blind randomized placebo-controlled trial of topical intranasal mometasone furoate nasal spray in children of adenoidal hypertrophy with otitis media with effusion[J].Am J Otolaryngol,2014,35(6):766-770.DOI:10.1016/j.amjoto.2014.06.006.
[26]LEE A.The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy[J].Int J Pediatr Otorhinolaryngol,2007,71(2):358.DOI:10.1016/j.ijporl.2006.08.017.
[27]WILLIAMSON I,BENGE S,BARTON S,et al.Topical intranasal corticosteroids in 4-11 year old children with persistent bilateral otitis media with effusion in primary care:double blind randomised placebo controlled trial[J].BMJ,2009,339:b4984.DOI:10.1136/bmj.b4984.
[28]李庆忠.鼻喷激素治疗分泌性中耳炎[C]//全国耳鼻咽喉头颈外科中青年学术会议论文集.济南,2012:124-125.
[29]RASHID M.Rationale and feasibility of intranasal delivery of drugs to the eustachian tube orifice[J].Curr Allergy Asthma Rep,2012,12(6):541-546.DOI:10.1007/s11882-012-0310-3.
[30]HUSSEIN A,FATHY H,AMIN S M,et al.Oral steroids alone or followed by intranasal steroids versus watchful waiting in the management of otitis media with effusion[J].J Laryngol Otol,2017,131(10):907-913.DOI:10.1017/s0022215117001700.
[31]MOORE R A,COMMINS D,BATES G,et al.S-carboxymethylcysteine in the treatment of glue ear:quantitative systematic review[J].BMC Fam Pract,2001(2):3.DOI:10.1186/1471-2296-2-3.
[32]DE LAS HERAS B,RODRíGUEZ B,BOSCá L,et al.Terpenoids:sources,structure elucidation and therapeutic potential in inflammation[J].Curr Top Med Chem,2003,3(2):171-185.DOI:10.2174/1568026033392462.
[33]WANG G Y,TANG W P,BIDIGARE R R.Terpenoids as therapeutic drugs and pharmaceutical agents[M].Germany:Springer,2003:197-227.
[34]JU H K,BAEK S H,AN R B,et al.Inhibitory effects of nardostachin on nitric oxide,prostaglandin E2,and tumor necrosis factor-alpha production in lipopolysaccharide activated macrophages[J].Biol Pharm Bull,2003,26(10):1375-1378.DOI:10.1248/bpb.26.1375.
[35]曲丽萍.化学计量学辅助GC-MS用于辛夷挥发油化学成分和抗炎作用机制研究[D].上海:第二军医大学,2010.
[36]黄兴雨,杨黎燕,尤静.薄荷挥发油研究进展[J].化工科技,2019,27(3):70-74.DOI:10.3969/j.issn.1008-0511.2019.03.015.
[37]魏亮,方洪壮,吴比,等.东北野生薄荷挥发油成分及抑菌活性研究[J].安徽农业科学,2019,47(10):170-172,178.DOI:10.3969/j.issn.0517-6611.2019.10.052.
[38]MATSUI S,MATSUMOTO H,SONODA Y,et al.Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line[J].Int Immunopharmacol,2004,4(13):1633-1644.DOI:10.1016/j.intimp.2004.07.023.
[39]TAKAHARA T,WATANABE A,SHIRAKI K.Effects of glycyrrhizin on hepatitis B surface antigen:a biochemical and morphological study[J].J Hepatol,1994,21(4):601-609.DOI:10.1016/s0168-8278(94)80108-8.
[40]PARK H Y,PARK S H,YOON H K,et al.Anti-allergic activity of 18beta-glycyrrhetinic acid-3-O-beta-D-glucuronide[J].Arch Pharm Res,2004,27(1):57-60.DOI:10.1007/BF02980047.
[41]ITO M,NAKASHIMA H,BABA M,et al.Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus[HIV (HTLV-III/LAV)][J].Antiviral Res,1987,7(3):127-137.DOI:10.1016/0166-3542(87)90001-5.
[42]ITO M,SATO A,HIRABAYASHI K,et al.Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV)[J].Antiviral Res,1988,10(6):289-298.DOI:10.1016/0166-3542(88)90047-2.
[43]CINATL J,MORGENSTERN B,BAUER G,et al.Glycyrrhizin,an active component of liquorice roots,and replication of SARS-associated coronavirus[J].Lancet,2003,361(9374):2045-2046.DOI:10.1016/s0140-6736(03)13615-x.
[44]LV Y X,ZHAO S P,ZHANG J Y,et al.Effect of orange peel essential oil on oxidative stress in AOM animals[J].Int J Biol Macromol,2012,50(4):1144-1150.DOI:10.1016/j.ijbiomac.2012.02.002.
[45]杨占秋,余宏.临床病毒学[M].北京:中国医药科技出版社,2000:177-204.
[46]THORNTON J L,CHEVALLIER K M,KOKA K,et al.The conductive hearing loss due to an experimentally induced middle ear effusion alters the interaural level and time difference cues to sound location[J].J Assoc Res Otolaryngol,2012,13(5):641-654.DOI:10.1007/s10162-012-0335-2.
[47]BROWN D T,MARSH R R,POTSIC W P.Hearing loss induced by viscous fluids in the middle ear[J].Int J Pediatr Otorhinolaryngol,1983,5(1):39-46.DOI:10.1016/s0165-5876(83)80006-8.
[48]WIEDERHOLD M L,ZAJTCHUK J T,VAP J G,et al.Hearing loss in relation to physical properties of middle ear effusions[J].Ann Otol Rhinol Laryngol Suppl,1980,89(3 Pt 2):185-189.DOI:10.1177/00034894800890s343.
[49]MARSH R R,BARANAK C C,POTSIC W P.Hearing loss and visco-elasticity of middle ear fluid[J].Int J Pediatr Otorhinolaryngol,1985,9(2):115-120.DOI:10.1016/s0165-5876(85)80011-2.
[50]RAVICZ M E,ROSOWSKI J J,MERCHANT S N.Mechanisms of hearing loss resulting from middle-ear fluid[J].Hear Res,2004,195(1/2):103-130.DOI:10.1016/j.heares.2004.05.010.
[51]JESELSOHN Y,FREEMAN S,SEGAL N,et al.Quantitative experimental assessment of the factors contributing to hearing loss in serous otitis media[J].Otol Neurotol,2005,26(5):1011-1015.DOI:10.1097/01.mao.0000185051.69394.01.
[52]LESPERANCE L,HANK BERNSTEIN L L.Guidelines for treating earaches in children[EB/OL].[2020-02-02].https://search.proquest.com/docview/1993085851?accountid=141446.
[53]MARTINES F,SALVAGO P,FERRARA S,et al.Factors influencing the development of otitis media among Sicilian children affected by upper respiratory tract infections[J].Braz J Otorhinolaryngol,2016,82(2):215-222.DOI:10.1016/j.bjorl.2015.04.002.
[54]WALKER R E,BARTLEY J,FLINT D,et al.Determinants of chronic otitis media with effusion in preschool children:a case-control study[J].BMC Pediatrics,2017,17:4.DOI:10.1186/s12887-016-0767-7.
[55]SKOLOUDIK L,KALFERT D,VALENTA T,et al.Relation between adenoid size and otitis media with effusion[J].Eur Ann Otorhinolaryngol Head Neck Dis,2018,135(6):399-402.DOI:10.1016/j.anorl.2017.11.011.
[56]广州中医学院.中医耳鼻喉科学[M].上海:上海科学技术出版社,1979:15-17.